Notably, re-emerged clonotypes in ISG-15+CD8+ T cells after treatment among EBV (+) patients were detected and associated with effector T population expressing CXCL13 in responsive EBV (+) tumor, indicating their significant importance in tumor immunochemotherapy response [25]. Here, CXCL13 is linked to neoplasm.